Apricot
PrivateLast Round
Series A
Oct 1, 2025
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Apricot is a healthcare technology company that provides an AI-native documentation platform to automate and streamline clinical workflows for post-acute care providers.
Sector
Healthcare & Life Sciences
Verticals
Vertical SaaS, Medical AI, Workflow Automation, EHR & EMR
Business Model
B2B
Customer Profile
Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Apricot Comparables
Compare Apricot with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Roger Healthcare | 94% | |
| io Health | 90% | |
| StenoHealth | 88% | |
Apricot Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 1, 2025 | ||||
| Seed | May 20, 2024 |
Apricot Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cortado Ventures | Series A, Seed |
| Insight Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Grew 19% QoQ, from 31 to 37 employees.
- Mar 11, 2026
Added Visiting Nurse Association of Ohio as a customer.
Apricot Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Apricot's valuation, stock price, and market status.